Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Stop Waiting For Johnson & Johnson To Break Up Or Down

Published 12/10/2014, 12:28 AM
Updated 05/14/2017, 06:45 AM

We all have seen the ‘V’ bottom in the market and in stocks that we either own or have been following. One that sticks out to me is Johnson & Johnson (NYSE:JNJ). It is in that large cap slice of the market that has been doing so well. And it is healthcare related, also a plus. It was also at all-time highs as the market sold off. The recovery brought it back to that all time high quickly. And it has done nothing for over a month since. Forget no more tears, it is keeping your baby powder dry. Both disappointing and uncharacteristic for it over the last year.

Johnson & Johnson Daily

The chart above shows that price action. As it sits in a tight range between 106.50 and 109.50 the Bollinger bands have been tightening. The momentum indicators are drifting lower, with the MACD pointing to more downside while the RSI is holding over the mid line for now, remaining in the bullish zone.

So which way is it going to break? I do not know. But I have a plan to trade it now anyway. When you see a tight consolidation in a stock for a long time with tightening Bollinger bands® it often foretells a move. This type of action can be played with options using a Straddle or Strangle. This is just a combination of a long put and a long call to participate in a move in either direction.

For Johnson & Johnson I like a January 23 Expiry 107/108 Strangle (offered at about $3.75 as i write). To make money the stock needs to move beyond either strike by the premium paid, $3.75, by Expiry, so either lower that 103.25 or above 111.75. That maybe a comfortable range for you. But if it is too wide then look at selling shorted dated Strangles to recoup some cost and narrow the range where the trade becomes profitable. For example, selling a December 105/110 Strangle narrows the range by 40 cents. Even better, if the stock does not break that December Strangle range by Expiry, you can sell another Strangle in early January.

The information in this blog post represents my own opinions and does not contain a recommendation for any particular security or investment. I or my affiliates may hold positions or other interests in securities mentioned in the Blog, please see my Disclaimer page for my full disclaimer.

Original post

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.